Singapore markets open in 2 hours 21 minutes

BioXcel Therapeutics, Inc. (BTAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.2800+0.0100 (+0.79%)
At close: 04:00PM EDT
1.2300 -0.05 (-3.91%)
After hours: 07:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
1,756
1,380
375
0
0
-
Cost of revenue
1,331
1,260
20
0
-
-
Gross profit
425
120
355
0
-
-
Operating expenses
Research development
67,927
84,326
91,239
52,708
57,995
-
Selling general and administrative
73,082
83,413
68,761
54,228
24,302
-
Total operating expenses
141,009
167,739
160,000
106,936
82,297
-
Operating income or loss
-140,584
-167,619
-159,645
-106,936
-82,297
-
Interest expense
13,554
13,314
8,213
40
27
-
Total other income/expenses net
-3,491
-3,769
-427
-
155
653
Income before tax
-153,048
-179,053
-165,757
-106,932
-82,169
-
Income from continuing operations
-153,048
-179,053
-165,757
-106,932
-82,169
-
Net income
-153,048
-179,053
-165,757
-106,931
-82,169
-
Net income available to common shareholders
-153,048
-179,053
-165,757
-106,931
-82,169
-
Basic EPS
-7.36
-6.15
-5.92
-4.05
-3.79
-
Diluted EPS
-7.36
-6.15
-5.92
-4.05
-3.79
-
Basic average shares
28,787
29,129
28,015
26,373
21,683
-
Diluted average shares
28,787
29,129
28,015
26,373
21,683
-